T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.45% |
| 2 | Consumer Discretionary | 13.78% |
| 3 | Financials | 12.98% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
ExxonMobil
XOM
$657B
| $2.76B | 0.6% |
29,384,306
+624,227
| +2% | +$62.2M |
|
27
Crown Castle
CCI
$31.4B
| $2.75B | 0.6% |
34,181,855
-2,496,177
| -7% | -$193M |
|
28
Johnson & Johnson
JNJ
$627B
| $2.74B | 0.6% |
25,744,385
-260,089
| -1% | -$27M |
|
29
Mastercard
MA
$493B
| $2.74B | 0.6% |
37,042,195
-109,076
| -0.3% | -$8.31M |
|
30
Thermo Fisher Scientific
TMO
$224B
| $2.71B | 0.59% |
22,265,883
+726,728
| +3% | +$88.4M |
|
31
State Street
STT
$51.4B
| $2.68B | 0.59% |
36,461,168
+2,088,916
| +6% | +$149M |
|
|
MRSH
32
Marsh
MRSH
$91.6B
| $2.63B | 0.57% |
50,204,241
+1,213,756
| +2% | +$63.3M |
|
33
Wells Fargo
WFC
$265B
| $2.61B | 0.57% |
50,265,483
-4,169,249
| -8% | -$214M |
|
34
Intuitive Surgical
ISRG
$141B
| $2.6B | 0.57% |
50,765,292
+12,376,404
| +32% | +$614M |
|
|
CELG
35
DELISTED
Celgene Corp
CELG
| $2.58B | 0.56% |
27,212,863
+563,522
| +2% | +$50.9M |
|
36
Sherwin-Williams
SHW
$88.5B
| $2.55B | 0.56% |
34,943,256
+983,799
| +3% | +$69.8M |
|
|
AMTD
37
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.5B | 0.55% |
74,972,438
-4,565,146
| -6% | -$148M |
|
38
Merck
MRK
$322B
| $2.5B | 0.55% |
44,201,794
-3,510,088
| -7% | -$197M |
|
39
Bank of America
BAC
$447B
| $2.49B | 0.54% |
146,178,037
+1,028,604
| +0.7% | +$16.4M |
|
40
Starbucks
SBUX
$122B
| $2.48B | 0.54% |
65,664,326
+1,576,610
| +2% | +$61M |
|
|
41
Alibaba
BABA
$306B
| $2.39B | 0.52% |
+26,922,443
| New | +$2.42B |
|
42
Pfizer
PFE
$152B
| $2.38B | 0.52% |
84,925,984
-3,303,723
| -4% | -$92.7M |
|
43
APA Corp
APA
$14.3B
| $2.38B | 0.52% |
25,339,627
+1,668,936
| +7% | +$165M |
|
44
Microsoft
MSFT
$3.74T
| $2.37B | 0.52% |
51,020,947
-3,254,288
| -6% | -$145M |
|
45
Ecolab
ECL
$79.8B
| $2.33B | 0.51% |
20,315,628
+58,716
| +0.3% | +$6.61M |
|
46
Bausch Health
BHC
$2.33B
| $2.3B | 0.5% |
17,497,210
+1,041,503
| +6% | +$124M |
|
47
Chipotle Mexican Grill
CMG
$40.6B
| $2.24B | 0.49% |
168,189,600
-8,077,850
| -5% | -$106M |
|
48
Roper Technologies
ROP
$39.5B
| $2.16B | 0.47% |
14,766,613
+977,892
| +7% | +$144M |
|
|
FISV
49
Fiserv Inc
FISV
$28.1B
| $2.15B | 0.47% |
66,621,628
+407,402
| +0.6% | +$12.9M |
|
50
Range Resources
RRC
$9.51B
| $2.14B | 0.47% |
31,517,956
+2,486,443
| +9% | +$190M |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.